Nitroprusside (often called sodium nitroprusside) is a powerful intravenous medication that rapidly lowers blood pressure by relaxing blood vessels. It has been used in the United States since its approval in 1981 and remains a go-to drug in intensive care settings for hypertensive emergencies and severe heart failure. Because it works within seconds and wears off just as fast when stopped, it gives medical teams precise, moment-to-moment control over dangerously high blood pressure.
How Nitroprusside Works
Nitroprusside belongs to a class of drugs called nitrovasodilators. Once it enters the bloodstream, it releases nitric oxide, a signaling molecule that tells the smooth muscle lining your arteries and veins to relax. As those blood vessels widen, the resistance your heart pumps against drops sharply, and blood pressure falls.
What makes nitroprusside unusual compared to a related drug like nitroglycerin is that it dilates both arteries and veins roughly equally. Nitroglycerin, by contrast, is a stronger dilator of veins than arteries. Nitroprusside’s balanced effect means it reduces both the workload on the heart (afterload) and the volume of blood returning to it (preload), which is why it can be useful in heart failure as well as pure blood pressure crises.
When It Is Used
Nitroprusside is reserved for situations where blood pressure is dangerously elevated and threatening to damage organs. The most common scenarios include:
- Hypertensive emergencies: Episodes where blood pressure spikes high enough to injure the brain, kidneys, heart, or blood vessels if not brought down quickly.
- Acute aortic dissection: A tear in the wall of the body’s largest artery, where the immediate goal is to reduce the force of blood against the damaged vessel. It is often paired with a heart-rate-lowering drug in this setting.
- Severe heart failure with pulmonary edema: When the heart is too weak to pump effectively and fluid backs up into the lungs, nitroprusside can lower the resistance the heart works against and improve blood flow.
An American Heart Association scientific statement lists nitroprusside among the first-line agents for these conditions, with an initial blood pressure target of reducing average pressure by 20 to 25 percent.
How It Is Given
Nitroprusside is only given as a continuous intravenous drip in a monitored setting, typically an ICU or emergency department. It cannot be taken as a pill. The infusion starts at a very low rate, around 0.3 micrograms per kilogram of body weight per minute, then gets adjusted upward every few minutes until blood pressure reaches the target. The average effective rate for most adults is about 3 micrograms per kilogram per minute, and the maximum allowed is 10 micrograms per kilogram per minute, though that ceiling should never be maintained for longer than 10 minutes.
One of nitroprusside’s defining features is its speed. Blood pressure begins to drop almost immediately after the infusion starts and climbs back up within minutes once it stops. This on-off quality is valuable in emergencies but also means patients need continuous blood pressure monitoring, usually through an arterial line, for the entire time they are receiving the drug.
Cyanide Toxicity: The Key Risk
The most serious concern with nitroprusside is cyanide buildup. When the drug interacts with hemoglobin in the blood, it breaks down into five cyanide molecules per molecule of nitroprusside. The body normally neutralizes cyanide by converting it to thiocyanate, a much less harmful substance that the kidneys filter out. But this detoxification step depends on a limited supply of sulfur donors in the body, and it can be overwhelmed if the drug is given too fast or for too long.
When cyanide accumulates faster than the body can clear it, cells lose the ability to use oxygen. Early warning signs include unexplained drops in blood oxygen levels and a shift toward acidic blood chemistry. If it progresses, cyanide toxicity can cause a slowing heart rate, confusion, seizures, and in extreme cases, death. This is why high infusion rates are limited to very short windows and why medical teams closely track acid-base balance during treatment.
Thiocyanate Buildup
Even after cyanide is successfully converted to thiocyanate, that byproduct can cause problems of its own if the kidneys can’t clear it fast enough. Thiocyanate becomes mildly toxic to the nervous system at blood levels around 60 mg/L, causing symptoms like ringing in the ears, constricted pupils, and exaggerated reflexes. At concentrations near 200 mg/L, it becomes life-threatening. For patients with normal kidney function, monitoring of thiocyanate levels is recommended whenever the cumulative dose exceeds 7 mg per kilogram per day. Patients with poor kidney function are at higher risk because they clear thiocyanate much more slowly, so their infusion rates are kept lower, typically no more than 1 microgram per kilogram per minute.
Nitroprusside vs. Nitroglycerin
These two drugs are often discussed together because both release nitric oxide and lower blood pressure. The practical difference comes down to which blood vessels they affect most. At moderate infusion rates (1.5 to 2 micrograms per kilogram per minute), nitroprusside is the more effective arterial dilator, while nitroglycerin dilates veins more powerfully. At very low rates, the two drugs perform similarly.
This distinction matters clinically. When the primary goal is to reduce the pressure the heart pumps against, such as during an aortic dissection, nitroprusside’s arterial effect is an advantage. When the goal is to reduce fluid overload by pooling blood in the veins and away from the lungs, nitroglycerin may be preferred. In practice, the choice also depends on cyanide risk: nitroglycerin has no cyanide concerns, making it a simpler option for longer infusions or patients with kidney problems.
What Patients Experience
If you or a family member is receiving nitroprusside, the experience typically involves being in an ICU bed with an arterial line in the wrist for real-time blood pressure readings and an IV pump delivering the drug at a carefully controlled rate. Nurses will adjust the drip frequently based on the blood pressure numbers. You may notice a headache, nausea, or lightheadedness as blood pressure drops, which are common and expected effects of the vasodilation.
Treatment duration varies widely. Some patients need the drug for only an hour or two while oral blood pressure medications are started. Others may require it for a day or more while the underlying crisis stabilizes. The medical team will typically transition to other medications as soon as possible to minimize the risk of cyanide and thiocyanate accumulation.